| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |